Literature DB >> 3103391

Fluctuation in response to chronic levodopa therapy: pathogenetic and therapeutic considerations.

T N Chase, J Juncos, C Serrati, G Fabbrini, G Bruno.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103391

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  6 in total

1.  Controlled release levodopa treatment of motor fluctuations in Parkinson's disease.

Authors:  J L Juncos; G Fabbrini; M M Mouradian; C Serrati; A M Kask; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

Review 2.  The immunological challenges of cell transplantation for the treatment of Parkinson's disease.

Authors:  Amanda L Piquet; Kala Venkiteswaran; Neena I Marupudi; Matthew Berk; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2012-04-11       Impact factor: 4.077

3.  On-off phenomenon in a child with tetrahydrobiopterin deficiency due to 6-pyruvoyl tetrahydropterin synthase deficiency (BH4 deficiency).

Authors:  Y Tanaka; N Matsuo; S Tsuzaki; K Araki; Y Tsuchiya; A Niederwieser
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

Review 4.  Spheramine for treatment of Parkinson's disease.

Authors:  Natividad P Stover; Ray L Watts
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

5.  Mathematical insights into the effects of levodopa.

Authors:  Michael C Reed; H Frederik Nijhout; Janet A Best
Journal:  Front Integr Neurosci       Date:  2012-07-04

Review 6.  Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Authors:  Dag Nyholm
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 5.577

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.